Teleflex Incorporated Teleflex Incorporated

Teleflex Incorporated

TFX

Classificação em ações #3215
Teleflex Incorporated is a global medical technology company dedicated to... Teleflex Incorporated is a global medical technology company dedicated to designing, developing, manufacturing, and distributing single-use medical devices. These products are crucial for diagnostic and therapeutic procedures, particularly within critical care and surgical environments worldwide. Its comprehensive product portfolio includes: Vascular Access Solutions: Featuring the "Arrow" brand, these include catheters, advanced catheter navigation and tip positioning systems, and intraosseous access systems. They are essential for administering intravenous therapies, monitoring blood pressure, and drawing blood samples, all achievable through a single access point. Interventional Cardiology & Radiology Products: This segment covers various coronary catheters, therapies for structural heart conditions, and devices for peripheral intervention and cardiac assist. Key users include interventional cardiologists, radiologists, and vascular surgeons. Specific offerings comprise Arrow, Guideline, and Trapliner catheters, the Manta Vascular Closure Device, and Arrow Oncontrol systems. Anesthesia and Surgical Products: The company provides anesthesia and pain management products, serving hospitals, emergency medical services, and military health organizations. Its surgical division offers metal and polymer ligation clips, fascial closure systems for laparoscopic procedures, percutaneous surgical systems, and a range of other surgical instruments. Interventional Urology & General Urology: Teleflex's interventional urology offerings prominently feature the UroLift System, an innovative treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). Additionally, it supplies general urology products like catheters, urine collection devices, catheterization accessories, and tools for operative endourology, alongside providing bladder management services. Respiratory Care Products: This category includes oxygen and aerosol therapy devices, spirometry equipment, and ventilation management systems, applicable across diverse healthcare settings. Teleflex serves a broad customer base, encompassing hospitals, healthcare providers, medical device manufacturers, and the home care market. Established in 1943, the company maintains its headquarters in Wayne, Pennsylvania.
Preço da ação
$131.01
Última sincronização: 2026-10-20
Valor de mercado
$5.55B
Variação (1 dia)
1.10%
Variação (1 ano)
-1.54%
País
US
Negociar Teleflex Incorporated (TFX)

Categoria

Healthcare
Rácio P/E de Teleflex Incorporated (TFX)
Rácio P/E em October 2026 TTM: -5.30
De acordo com os últimos relatórios financeiros e o preço das ações da Teleflex Incorporated, o rácio P/E atual (TTM) é -5.30. No final de 2023, a empresa tinha um P/E de 32.87.
Histórico do rácio P/E da Teleflex Incorporated de 2000 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
2026 (TTM) -5.30 -104.43%
2024 119.64 263.93%
2023 32.87 1.97%
2022 32.24 1.85%
2021 31.65 -44.52%
2020 57.06 51.40%
2019 37.69 -35.92%
2018 58.81 -19.89%
2017 73.41 149.60%
2016 29.41 31.84%
2015 22.31 -11.85%
2014 25.31 -1.03%
2013 25.57 -266.80%
2012 -15.33 -299.68%
2011 7.68 -28.10%
2010 10.68 51.16%
2009 7.06 -57.34%
2008 16.56 -1.95%
2007 16.89 -8.27%
2006 18.41 -3.49%
2005 19.08 -91.25%
2004 218.11 1,134.01%
2003 17.68 32.21%
2002 13.37 -18.05%
2001 16.31 5.58%
2000 15.45 0.00%
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
47.48 -996.61%
US
27.43 -617.86%
FR
- -
JP
56.89 -1,174.29%
US
- -
CH
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.